In:
Antioxidants, MDPI AG, Vol. 12, No. 9 ( 2023-09-18), p. 1773-
Abstract:
Hypertension and derived cardiovascular disease (CVD) are among the leading causes of death worldwide. Increased oxidative stress and inflammatory state are involved in different alterations in endothelial functions that contribute to the onset of CVD. Polyphenols, and in particular anthocyanins, have aroused great interest for their antioxidant effects and their cardioprotective role. However, anthocyanins are rarely detected in blood serum because they are primarily metabolized by the gut microbiota. This review presents studies published to date that report the main results from clinical studies on the cardioprotective effects of anthocyanins and the role of the gut microbiota in the metabolism and bioavailability of anthocyanins and their influence on the composition of the microbiota. Even if it seems that anthocyanins have a significant effect on vascular health, more studies are required to better clarify which molecules and doses show vascular benefits without forgetting the crucial role of the microbiota.
Type of Medium:
Online Resource
ISSN:
2076-3921
DOI:
10.3390/antiox12091773
Language:
English
Publisher:
MDPI AG
Publication Date:
2023
detail.hit.zdb_id:
2704216-9
SSG:
15,3
